Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Pre-treatment 18F-FDG PET/CT Radiomics predict local recurrence in patients treated with stereotactic radiotherapy for early-stage non-small cell lung cancer: a multicentric study

Gurvan Dissaux, Dimitris Visvikis, Ronrick Do-ano, Olivier Pradier, Enrique Chajon, Isabelle Barillot, Loig Duverge, Ingrid Masson, Ronan Abgral, Maria-Joao Santiago Ribeiro, Anne Devillers, Amandine Pallardy, Vincent Fleury, Marc-André Mahé, Renaud De Crevoisier, Mathieu Hatt and Ulrike Schick
Journal of Nuclear Medicine November 2019, jnumed.119.228106; DOI: https://doi.org/10.2967/jnumed.119.228106
Gurvan Dissaux
1 Radiation Oncology Department, University Hospital, Brest, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dimitris Visvikis
2 LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronrick Do-ano
2 LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Pradier
1 Radiation Oncology Department, University Hospital, Brest, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Enrique Chajon
3 Radiotherapy Department, Centre Eugene Marquis, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Isabelle Barillot
4 Department of Radiation Oncology (CORAD), University Hospital, Tours, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Loig Duverge
5 Radiotherapy Department, Centre Eugene Marquis, Rennes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ingrid Masson
6 Department of Radiation Oncology, Institut de Cancerologie de l'Ouest, Saint-Herblain, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronan Abgral
7 Nuclear Medicine department, University Hospital, Brest, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria-Joao Santiago Ribeiro
8 Nuclear Medicine department, University Hospital, Tours, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Devillers
9 Nuclear Medicine department, Centre Eugene Marquis, Rennes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amandine Pallardy
10 Nuclear Medicine department, University Hospital, Nantes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Fleury
11 Nuclear Medicine department, Institut de Cancerologie de l'Ouest, Saint-Herblain, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc-André Mahé
6 Department of Radiation Oncology, Institut de Cancerologie de l'Ouest, Saint-Herblain, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renaud De Crevoisier
5 Radiotherapy Department, Centre Eugene Marquis, Rennes, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mathieu Hatt
2 LaTIM, INSERM, UMR 1101, Univ Brest, Brest, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ulrike Schick
1 Radiation Oncology Department, University Hospital, Brest, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Abstract

Purpose: The aim of this retrospective multicentric study was to develop and evaluate a prognostic FDG PET/CT radiomics signature in early-stage non-small cell lung cancer (NSCLC) patients treated with stereotactic radiotherapy (SBRT). Material and Methods: Patients from 3 different centers (n = 27, 29 and 8) were pooled to constitute the training set, whereas the patients from a fourth center (n = 23) were used as the testing set. The primary endpoint was local control (LC). The primary tumour was semi-automatically delineated in the PET images using the Fuzzy locally adaptive Bayesian algorithm, and manually in the low-dose CT images. A total of 184 IBSI-compliant radiomic features were extracted. Seven clinical and treatment parameters were included. We used ComBat to harmonize radiomic features extracted from the four institutions relying on different PET/CT scanners. In the training set, variables found significant in the univariate analysis were fed into a multivariate regression model and models were built by combining independent prognostic factors. Results: Median follow-up was 21.1 (1.7 – 63.4) and 25.5 (7.7 – 57.8) months in training and testing sets respectively. In univariate analysis, none of the clinical variables, 2 PET and 2 CT features were significantly predictive of LC. The best predictive models in the training set were obtained by combining one feature from PET, namely information correlation 2 (IC2) and one from CT (Flatness), reaching a sensitivity of 100% and a specificity of 96%. Another model combining 2 PET features (IC2 and Strength), reached sensitivity of 100% and specificity of 88%, both with an undefined hazard ratio (HR) (p<0.001). The latter model obtained an accuracy of 0.91 (sensitivity 100%, specificity 81%), with a HR undefined (P = 0.023) in the testing set, however other models relying on CT radiomics features only or the combination of PET and CT features failed to validate in the testing set. Conclusion: We showed that two radiomic features derived from FDG PET were independently associated with LC in patients with NSCLC undergoing SBRT and could be combined in an accurate predictive model. This model could provide local relapse-related information and could be helpful in clinical decision-making.

  • Oncology: Lung
  • PET/CT
  • Radiation Therapy Planning
  • PET/CT
  • early stage NSCLC
  • radiomics
  • stereotactic radiotherapy
  • Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pre-treatment 18F-FDG PET/CT Radiomics predict local recurrence in patients treated with stereotactic radiotherapy for early-stage non-small cell lung cancer: a multicentric study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Pre-treatment 18F-FDG PET/CT Radiomics predict local recurrence in patients treated with stereotactic radiotherapy for early-stage non-small cell lung cancer: a multicentric study
Gurvan Dissaux, Dimitris Visvikis, Ronrick Do-ano, Olivier Pradier, Enrique Chajon, Isabelle Barillot, Loig Duverge, Ingrid Masson, Ronan Abgral, Maria-Joao Santiago Ribeiro, Anne Devillers, Amandine Pallardy, Vincent Fleury, Marc-André Mahé, Renaud De Crevoisier, Mathieu Hatt, Ulrike Schick
Journal of Nuclear Medicine Nov 2019, jnumed.119.228106; DOI: 10.2967/jnumed.119.228106

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Pre-treatment 18F-FDG PET/CT Radiomics predict local recurrence in patients treated with stereotactic radiotherapy for early-stage non-small cell lung cancer: a multicentric study
Gurvan Dissaux, Dimitris Visvikis, Ronrick Do-ano, Olivier Pradier, Enrique Chajon, Isabelle Barillot, Loig Duverge, Ingrid Masson, Ronan Abgral, Maria-Joao Santiago Ribeiro, Anne Devillers, Amandine Pallardy, Vincent Fleury, Marc-André Mahé, Renaud De Crevoisier, Mathieu Hatt, Ulrike Schick
Journal of Nuclear Medicine Nov 2019, jnumed.119.228106; DOI: 10.2967/jnumed.119.228106
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Impact of ComBat Harmonization on PET Radiomics-Based Tissue Classification: A Dual-Center PET/MRI and PET/CT Study
  • Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?
  • Quo Vadis, Molecular Imaging?
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Oncology: Lung)

  • First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients
  • Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study
Show more Clinical (Oncology: Lung)

Similar Articles

Keywords

  • Oncology: Lung
  • PET/CT
  • radiation therapy planning
  • early stage NSCLC
  • radiomics
  • stereotactic radiotherapy
SNMMI

© 2025 SNMMI

Powered by HighWire